Building confidence & reliability

Radiopharmaceuticals

Radionuclides

Chelatec helps you developing your future radiopharmaceuticals in the following application areas:

► PET Imaging: ¹²⁴I, ⁶⁴Cu, ⁶⁸Ga, ⁸⁹Zr, ⁸⁶Y
► SPECT Imaging: ¹²³I, ¹¹¹In, ^99mTc
► Beta-Radiotherapy: ¹³¹I, ⁹⁰Y, ⁶⁷Cu, ¹⁶⁶Ho, ¹⁵³Sm, ^186/188Re, ¹⁷⁷Lu
► Alpha-Radiotherapy: ²¹¹At

Radioimmunoconjugates

Chelatec supports the complete development of Radioimmunoconjugates from their synthesis to the issuance of a "ready to use" kit.   This process integrates different stages:

► Preparation and characterization of immunoconjugates
► Chelates:Antibody ratio assessment 
► Optimisation of radiolabeling conditions
► Validation of labeling procedure 
► Quality controls, Stability, Immunoreactivity
► Preclinical studies in rodents 
► Assessment of therapeutic efficiency 
► Technological transfer